February 11/Pharma Business Week -- Docosahexaenoic acid (DHA) omega-3 innovator and maker of the life'sDHA brand of DHA, Martek Biosciences announced it has entered into a license agreement with General Mills for a patented microencapsulation technology. Microencapsulation is a process widely used in food manufacturing that protects the integrity of food ingredients and helps maintain the nutritional value, shelflife and flavor of the finished food or beverage product.
Developed by General Mills, this technology is anticipated to enhance Martek's ability to produce DHA powders for certain food applications, particularly long shelflife products and applications with sensory and formulation challenges. Under the terms of the agreement, Martek is granted a perpetual and generally exclusive license, with respect to third parties, to the General Mills technology for use with DHA and other polyunsaturated fatty acids. General Mills retains the right to this technology for its own use and exclusively for all uses within some of its core businesses.